Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by EvoEndo, Inc.

News headline image
EvoEndo® Surpasses 3,000 Sedation-Free Transnasal Endoscopy Procedures Nationwide
From EvoEndo, Inc.
Via Business Wire
News headline image
Nicklaus Children's Hospital is First in Region to Offer Sedation-Free Evaluation of Upper Gastrointestinal Tract in Children
From EvoEndo, Inc.
Via Business Wire
News headline image
EvoEndo® Endoscopy System Receives FDA Clearance for All Ages
From EvoEndo, Inc.
Via Business Wire
News headline image
EvoEndo Introduces Additional Gastroscope for Sedation-Free TNE
From EvoEndo, Inc.
Via Business Wire
News headline image
Leading Academic Medical Center Becomes First in North Carolina to Offer Sedation-Free TNE With the EvoEndo® Endoscopy System
From EvoEndo, Inc.
Via Business Wire
News headline image
Expanding Access to Sedation-Free TNE with the EvoEndo® Endoscopy System
From EvoEndo, Inc.
Via Business Wire
News headline image
Dr. Matthew Ryan Reaches Milestone 100+ TNEs with the EvoEndo® Endoscopy System
From EvoEndo, Inc.
Via Business Wire
News headline image
EvoEndo Elects David Pierce to the Board of Directors
From EvoEndo, Inc.
Via Business Wire
News headline image
Children’s Hospital Los Angeles is the First in California to Use the EvoEndo® System for Unsedated Pediatric Endoscopy
From EvoEndo, Inc.
Via Business Wire
News headline image
EvoEndo® Announces Key Leadership Transitions
From EvoEndo, Inc.
Via Business Wire
News headline image
EvoEndo Announces Ambulatory Payment Classification (APC) Reassignments for Flexible Transnasal Esophagogastroduodenoscopy (EGD)
From EvoEndo, Inc.
Via Business Wire
News headline image
EvoEndo Poised to Transform Clinical Endoscopy Practice With The EvoEndo® Single-Use Unsedated Transnasal Endoscopy (TNE) System
From EvoEndo, Inc.
Via Business Wire
News headline image
EvoEndo® and Micro-Tech Endoscopy Announce Partnership for Single-Use Unsedated Endoscopy System
From EvoEndo, Inc.
Via Business Wire
News headline image
EvoEndo® Raises $10.1 Million to Make Unsedated Transnasal Endoscopy a Reality for Patients and Physicians
From EvoEndo, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.